Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...
Health and Me on MSN11h
Urologist Shares 'Itchy And Ugly' Symptoms Of Kidney Diseases Visible On Your Skin
Your skin might be telling you something serious! Unexplained itching, discoloration, or extreme dryness could be hidden ...
Le Lézard22h
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDxtm (glucagon) for Use as a Diagnostic Aid
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, ...